Article
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
21 May 2022
Abstract excerpt
Parkinson's disease (PD) is a chronic progressive neurodegenerative disease that is increasingly becoming a global threat to the health and life of the elderly worldwide. Although there are some drugs clinically available for treating PD, these treatments can only alleviate the symptoms of PD patients but cannot completely cure the disease. Therefore, exploring other potential mechanisms to develop more effective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
